MKMilena A. Keren

Milena A. Keren

*This is an algorithmically generated author record based on publicly available information.

Milena A. Keren has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reserves for reducing mortality from cardiovascular diseases in patients after heart and vascular surgery: possibilities of lipid-lowering therapy

    by M. A. Murashko, E. Z. Golukhova, V. Yu. Semenov, M. A. Keren, T. V. Zavalikhina, V. V. Omelyanovskiy, O. S. Kobyakova, I. P. Shibalkov, М. А. Мурашко, Е. З. Голухова, et al.

    Introduction. Statins reduce the risk of recurrence of cardiovascular events and improve the survival of patients with atherosclerosis, including survival in patients after heart and vascular surgery. However, no more than 10% of patients after heart and vascular surgery are in the target range of low-density lipoproteins. The purpose of the study was to conduct a clinical and economic analysis of the intensification of lipid-lowering therapy in patients who underwent heart and vascular surgery. Materials and methods. The total mortality was modeled for 10 years in patients who underwent surgery for heart and vascular diseases in the Russian Federation. Next, the calculations of the number of lives saved and the total number of years of life saved for 1, 5 and 10 years after heart and vascular surgery were carried out. Based on the approximated survival function, the expected number of deaths in the cohort during the 10-year follow-up period was estimated for each group under consideration. The number of lives saved was calculated as the difference between the expected number of deaths in the baseline scenario and in the intervention scenario over the corresponding time horizon. The number of life years saved was defined as the area under the survival curve during the simulation period (10 years). The additional life years saved were calculated as the difference between the results in the intervention scenario and in the baseline scenario. Then, based on the data obtained, a clinical and economic analysis of the expansion of lipid-lowering therapy was carried out by adding rosuvastatin 10–40 mg and ezetimibe 10 mg to the list of vital and essential medicines for secondary prevention after heart and vascular surgery. Results. Intensification of lipid-lowering therapy through the use of high-intensity statins (including rosuvastatin) and their combination with ezetimibe in patients undergoing surgery for heart and vascular diseases will save 17,165 lives within 10 years, which will save 97,553 years of life. An assessment of the economic costs showed that providing ten years of intensive lipid-lowering therapy for patients undergoing heart and vascular surgery would require additional funds in the amount of 14,356.725 million rubles. Conclusion. Expanding the possibilities of secondary prevention after heart and vascular surgery by enhancing lipid-lowering therapy (including rosuvastatin 20–40 mg in combination with ezetimibe) leads to a long-term reduction in postoperative mortality. An increase in costs per patient by an average of 4,046.97 rubles per year will save 97.5 thousand years of life for 10 years. At the same time, the amount of additional costs per saved year of life is significantly lower than the current Russian threshold for willingness to pay per saved year of quality life.

  • Open Access

    Comparison of the effectiveness of glomerular filtration rate (GFR) estimation equations for predicting in-hospital outcomes after coronary artery bypass grafting

    by M. A. Keren, A. I. Osipova, K. B. Yakhyaeva, M. L. Mamalyga, T. V. Zavalikhina, I. V. Volkovskaya, I. Yu. Sigaev, E. Z. Golukhova

    Aim . To compare the effectiveness of glomerular filtration rate (GFR) estimation equations (CKD-EPI, MDRD, MCQ, Cockcroft-Gault) in predicting in-hospital death and/or acute renal failure in patients with coronary artery disease (CAD) after coronary artery bypass grafting (CABG). Material and methods . An analysis of anonymized medical data from 2600 patients with stable CAD who underwent elective isolated CABG. All patients underwent renal function assessment using four equations (CKD-EPI, MDRD, MCQ, and CockcroftGault) and were then divided into groups based on their baseline GFR level: group 1 — patients with high or optimal renal function (GFR ≥90 ml/min/1,73 m2), group 2 — patients with slightly reduced GFR (60-89,9 ml/min/1,73 m 2 ), group 3 — patients with moderately reduced GFR (45-59,9 ml/min/1,73 m 2 ), group 4 — patients with significantly reduced GFR (30-44,9 ml/min/1,73 m 2 ), group 5 — patients with extremely reduced GFR (60 ml/min/1,73 m 2 ). The MDRD equation was less reliable in predicting adverse postoperative outcomes. The data obtained regarding the effectiveness of the above formulas, including the Cockcroft-Gault one, in patients with lower GFR require verification in studies with larger sample sizes. This will allow the development of more precise practice recommendations.

  • Прогностическая значимость остаточного балла по шкале SYNTAX после коронарного стентирования

    by М.а. Керен, И.ю. Сигаев, Е.л. Закревский, К.б. Яхяева, Н.т. Одишария, М.к. Мусаев, Т.в. Завалихина, И.в. Ключников, И.в. Волковская, С.а. Авакова

  • Прогнозирование осложнений после операции коронарного шунтирования у больных с ожирением

    by К.б. Яхяева, М.а. Керен, И.ю. Сигаев, И.в. Волковская, М.л. Мамалыга, Т.в. Завалихина, Д.г. Гелашвили, Е.а. Космачева

  • MODERN ASPECTS OF PATHOPHYSIOLOGY AND DIAGNOSTICS OF HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION

    by Diana P. Paraskevova, Anton V. Minaev, Tatyana O. Astrakhantseva, Milena A. Keren

    Highlights The pathophysiology of heart failure with preserved ejection fraction differs from heart failure with low ejection fraction. There are modern scales (HFA-PEFF and H2FPEF) that show the probability of heart failure with preserved ejection fraction. The sensitivity and specificity of both scales are insufficient. New research is needed. Abstract HFpEF is a common disease. It has a poor outlook due to high death rates and complex drug treatments. The article describes a modern view of HFpEF's pathophysiology. It focuses on the causes of myocardial remodeling. It also presents new algorithms for diagnosing HFpEF. The triggers for HFpEF are activation of the neuroendocrine system, low-level inflammation, and myocardial fibrosis. The causes and mechanisms of HFpEF are complex. So, researchers must revise current diagnostic methods. New risk scales, HFA-PEFF and H2FPEF, aim to identify HFpEF patients. Researchers are still studying their effectiveness. Using both imaging and lab tests gives a complete view of heart changes. This helps detect HFpEF with greater accuracy. The low agreement between these scales shows a need for more study of HFpEF patients, given their phenotyping. This may help develop simpler diagnostic algorithms.

  • Open Access

    Comparison of coronary artery bypass grafting and stenting depending on the clinical and anatomical scenario: data from the retrospective single-center cohort study

    by E. Z. Golukhova, I. Yu. Sigaev, M. A. Keren, T. V. Zavalikhina, K. V. Petrosyan, K. B. Yakhyaeva, I. V. Volkovskaya, S. A. Avakova

    Aim. To assess the long-term all-cause mortality after percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in patients with stable coronary artery disease (CAD) under various clinical and anatomical scenarios.Material and methods. This single-center cohort retrospective study assessed the outcomes of CABG and PCI with implantation of second-generation drugeluting stents in 4177 patients with stable CAD. Inhospital, 30-day and remote 5-year all-cause mortality (mean follow-up period — 38 months) was assessed. Also, the influence of the initial severity of CAD, the presence/absence of diabetes, myocardial contractility on remote all-cause mortality after myocardial revascularization was assessed.Results. Inhospital and 30-day risks of death in patients who underwent PCI and CABG, after comparing the initial clinical characteristics, did not differ significantly. In the long-term follow-up period, PCI compared with CABG was associated with an increased all-cause mortality in the main groups (PCI vs CABG: odds ratio (OR) 1,84, 95% confidence interval (CI) 1,30-2,62, p50% (OR 5,04, 95% CI 1,72-14,76, p=0,003), but not in patients with single-vessel disease (OR 2,084, 95% CI 0,9964,361, p=0,051). Diabetes in the main study groups did not affect the difference in mortality as follows: CABG had an advantage over PCI regardless of diabetes. However, CABG in patients with multivessel disease and diabetes, in contrast to patients without diabetes, led to a significant decrease in all-cause death risk (OR 2,29, 95% CI 1,173-4,47, p=0,015). Also, PCI compared with CABG was accompanied by an increase in the 5-year death risk in patients with an not reduced left ventricular ejection fraction (LVEF) >40% (OR 1,74, 95% CI 1,205-2,536, p=0,003), but not in patients with LVEF 50%, lesion of two or more coronary arteries), with concomitant diabetes in multivessel disease, and patients with non-reduced LVEF (>40%).


  • Prognosis of Early Outcomes after Isolated Coronary Bypass Surgery: Results of a Single-Center Cohort Study

    by Elena Z. Golukhova, Milena A. Keren, Tatiana V. Zavalikhina, Naida I. Bulaeva, Damir I. Marapov, Igor Y. Sigaev, Vadim Yu. Merzlyakov, Mikhail D. Alsibaya, Irina V. Volkovskaya, Kumushdzhan B. Yakhiaeva, et al.

    Background. The importance of predictors of adverse outcomes after coronary bypass surgery needs to be regularly review in view of changing standards of practice. Predicting complications will help reduce current mortality and morbidity among patients who have undergone coronary bypass surgery (CABG). Aims prediction and determination of independent predictors of in-hospital mortality after CABG based on the results of preoperative examination. Methods. In a retrospective cohort single-center study, we analyzed the results of 2239 patients who underwent isolated CABG for the period from September 2018 to August 2021. The primary endpoint of the study was hospital death after CABG. Also, the frequency of: non-fatal myocardial infarction, non-fatal stroke, acute heart failure, postoperative rhythm and conduction disorders, acute renal failure, multiple organ failure, infectious complications was analyzed. Next, we searched for independent predictors and built a prognostic model for assessing the risk of death after CABG. Results. Results. Hospital mortality among patients was 1.34% (n = 30). Independent predictors of death after CABG were: ejection fraction (OR 0.91; 95% CI: 0.880.93; p 0.001), body mass index (OR 0.90; 95% CI: 0.820.99; p = 0.035), glomerular filtration rate (OR 0.97; 95% CI: 0.960.99; p = 0.005), repeated CABG (OR 9.3; 95% CI: 2.7431.24; p 0.001), critical atherosclerotic lesion of the arteries of the lower extremities (OR 4.5; 95% CI: 1.93310.268; p 0.001). The model for predicting the probability of death after CABG had high quality metrics: ROC-AUC 0.838 (95% CI: 0.7470.929; p 0.001), sensitivity 72.4%, specificity 84%. The threshold value of the logistic function P at the cut-off point, which corresponded to the highest value of the Yuden index, was 0.015. The outcome was predicted when the value of the logistic function P was higher than or equal to this value. Conclusion. We have developed a model for predicting in-hospital mortality after CABG based on independent linear predictors: left ventricular ejection fraction, body mass index, glomerular filtration rate, repeated CABG, critical atherosclerotic lesion of the main arteries of the lower extremities.


  • Open Access

    Potential of machine learning methods in operational risk stratification in patients with coronary artery disease scheduled for coronary bypass surgery

    by E. Z. Golukhova, M. A. Keren, T. V. Zavalikhina, N. I. Bulaeva, D. S. Akatov, I. Yu. Sigaev, K. B. Yakhyaeva, D. A. Kolesnikov

    Aim. To develop and evaluate the effectiveness of models for predicting mortality after coronary bypass surgery, obtained using machine learning analysis of preoperative data.Material and methods. As part of a cohort study, a retrospective prediction of in-hospital mortality after coronary artery bypass grafting (CABG) was performed in 2182 patients with stable coronary artery disease. Patients were divided into 2 following samples: learning (80%, n=1745) and training (20%, n=437). The initial ratio of surviving (n=2153) and deceased (n=29) patients in the total sample indicated a pronounced class imbalance, and therefore the resampling method was used in the training sample. Five machine learning (ML) algorithms were used to build predictive risk models: Logistic regression, Random Forrest, CatBoost, LightGBM, XGBoost. For each of these algorithms, cross-validation and hyperparameter search were performed on the training sample. As a result, five predictive models with the best parameters were obtained. The resulting predictive models were applied to the learning sample, after which their performance was compared in order to determine the most effective model.Results. Predictive models implemented on ensemble classifiers (CatBoost, LightGBM, XGBoost) showed better results compared to models based on logistic regression and random forest. The best quality metrics were obtained for CatBoost and LightGBM based models (Precision — 0,667, Recall — 0,333, F1-score — 0,444, ROC AUC — 0,666 for both models). There were following common high-ranking parameters for deciding on the outcome for both models: creatinine and blood glucose levels, left ventricular ejection fraction, age, critical stenosis (>70%) of carotid arteries and main lower limb arteries.Conclusion. Ensemble machine learning methods demonstrate higher predictive power compared to traditional methods such as logistic regression. The prognostic models obtained in the study for preoperative prediction of in-hospital mortality in patients referred for CABG can serve as a basis for developing systems to support medical decision-making in patients with coronary artery disease.